Bruce D. Minsky

Active 1987–2024

172
Papers
28,267
Citations
99
h-index
166
i10-index

Citations

Citations per year for Bruce D. Minsky1984: 1 citations1988: 7 citations1989: 8 citations1990: 5 citations1991: 10 citations1992: 10 citations1993: 17 citations1994: 19 citations1995: 24 citations1996: 24 citations1997: 46 citations1998: 40 citations1999: 53 citations2000: 78 citations2001: 86 citations2002: 115 citations2003: 94 citations2004: 166 citations2005: 234 citations2006: 237 citations2007: 185 citations2008: 193 citations2009: 175 citations2010: 211 citations2011: 229 citations2012: 175 citations2013: 186 citations2014: 156 citations2015: 148 citations2016: 100 citations2017: 136 citations2018: 112 citations2019: 535 citations2020: 621 citations2021: 500 citations2022: 365 citations2023: 240 citations2024: 419 citations2025: 141 citations2026: 9 citations1985–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,874 citing papers, 27.9% of this breakdownChina: 645 citing papers, 9.6% of this breakdownUnited Kingdom: 462 citing papers, 6.9% of this breakdownNetherlands: 384 citing papers, 5.7% of this breakdownItaly: 350 citing papers, 5.2% of this breakdownGermany: 327 citing papers, 4.9% of this breakdownFrance: 261 citing papers, 3.9% of this breakdownCanada: 258 citing papers, 3.8% of this breakdownJapan: 244 citing papers, 3.6% of this breakdownSouth Korea: 179 citing papers, 2.7% of this breakdownAustralia: 177 citing papers, 2.6% of this breakdownSpain: 154 citing papers, 2.3% of this breakdown
0%27.9%Other 20.9%

Fields

  • Medicine83.9%
  • Biochemistry, Genetics and Molecular Biology8.3%
  • Physics and Astronomy4.2%
  • Engineering0.7%
  • Computer Science0.6%
  • Immunology and Microbiology0.4%
  • Other1.9%

Topics

  • Colorectal Cancer Surgical Treatments12.7%
  • Colorectal and Anal Carcinomas9%
  • Esophageal Cancer Research and Treatment6.2%
  • Colorectal Cancer Treatments and Studies4.2%
  • Gastric Cancer Management and Outcomes4.1%
  • Colorectal Cancer Screening and Detection4%
  • Other59.8%

Coauthors

All papers

Open in search
  1. International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Reviews Clinical Oncology 2021 cited by 244

  2. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

    Authors: , , , , , , , , - Journal of Clinical Oncology 2002 cited by 1,130

  3. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

    Authors: , , , , , , , , , , , , , , - Annals of Oncology 2015 cited by 357

  4. Colorectal cancer

    Authors: , , , , , , - The Lancet 2010 cited by 1,355

  5. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants

    Authors: , , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 229

  6. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

    Authors: - Journal of Clinical Oncology 2002 cited by 1,351

  7. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alison Tree, Baukelien van Triest, William A. Hall, Helena M. Verkooijen - Frontiers in Oncology 2020 cited by 151

  8. Follow-Up Care, Surveillance Protocol, and Secondary Prevention Measures for Survivors of Colorectal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement

    Authors: , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 370

  9. Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 cited by 350

  10. Outcome measures in multimodal rectal cancer trials

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 104

  11. Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum

    Authors: , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2009 cited by 527

  12. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer

    Authors: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2005 cited by 426

  13. Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation

    Authors: , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2015 cited by 369

  14. Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy

    Authors: , , , , , , , , , , , , , , , - Radiotherapy and Oncology 2017 cited by 156

  15. Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 609

  16. NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience

    Authors: , , , , , , , , , , , , , , , , , , - Clinical and Translational Radiation Oncology 2022 cited by 68

  17. The transformation of radiation oncology using real-time magnetic resonance guidance: A review

    Authors: , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2019 cited by 182

  18. A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology

    Authors: , , , , , , , , , , , - Annals of Surgical Oncology 2020 cited by 71

  19. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials

    Authors: , , , , , , , , , , , , , , , , , , , , - European Journal of Cancer 2020 cited by 67

  20. Performance Status Restriction in Phase III Cancer Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the National Comprehensive Cancer Network 2020 cited by 44

  21. An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2017 cited by 134

  22. Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer

    Authors: , , , , , , , , , , , - New England Journal of Medicine 1998 cited by 1,361

  23. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatocellular Carcinoma 2021 cited by 46

  24. The radiotherapy quality assurance gap among phase III cancer clinical trials

    Authors: , , , , , , , , , , , , , , , , - Radiotherapy and Oncology 2021 cited by 29